Founder, Senior Managing Partner & CEO, Flagship Pioneering
Noubar Afeyan leads Flagship Pioneering, a firm that conceives, creates, resources and develops first-in-category life science ventures. Throughout his long-standing career as inventor, entrepreneur, CEO and venture capitalist, Noubar has co-founded and built more than 40 companies, including Moderna Therapeutics and Seres Therapeutics. Noubar holds his Ph.D. from MIT, has authored numerous scientific publications, and has received patents for his work across multiple fields. Noubar frequently speaks about life sciences entrepreneurship, innovation, and biological engineering. He serves on a number of corporate boards, including those of, Codiak Biosciences, Evelo BioSciences, Joule Unlimited and Axcella.
Noubar received a 2012 Technology Pioneer award from the World Economic Forum. He has served as chairman of the Global Agenda Council on Chemicals, Advanced Materials and Biotechnology of the World Economic Forum, is a member of the Meta-Council on Emerging Technologies, and currently sits on the MIT Corporation Board. Noubar also received the Ellis Island Medal of Honor, which recognizes Americans who have distinguished themselves as US citizens and who have enabled their ancestry groups to maintain their identities while becoming integral parts of American life.